AnnexinA5 Might Suppress the Phenotype of Human Gastric Cancer Cells
ERK pathway
anexinA5
apoptosis
gastric cancer
invasion
migration
proliferation
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2021
2021
Historique:
received:
07
02
2021
accepted:
19
04
2021
entrez:
31
5
2021
pubmed:
1
6
2021
medline:
1
6
2021
Statut:
epublish
Résumé
Gastric cancer is one of the most fatal diseases around the world. However, the mechanism of the development of gastric cancer is still not clarified. In addition, the anticancer drugs have cytotoxicity with different degrees. AnnexinA5, a member of the annexin family, has a great binding ability with the membrane phospholipid in a calcium dependent manner and is involved in the development of various cancers. This study aims to explore the influence of annexinA5 on human gastric cancer cells and whether it has the potential to be an auxiliary treatment to gastric cancer. In this study, the role of annexinA5 was detected from both the endogenous and the exogenous aspects on the gastric cancer cell lines MGC-803 and MKN-45. The cells were divided into a knockdown group in which RNA interference technique was used to suppress annexinA5 expression and a protein-supplementing group in which annexinA5 protein was added in the culture supernatant. After the suppression ratio of RNA interference was determined and the IC50 of annexinA5 protein was decided respectively, the cells' proliferation was detected by MTT assay, colony formation assay, and the expression of PCNA. FCM assay and PI staining methods were applied to test cell apoptosis and necrosis. To investigate whether ANXA5 influence cell metastasis, wound healing assay and transwell assay were employed. To further detect the mechanism of annexinA5 action, the signal pathway was examined with Western Blot method. When ANXA5 gene was knocked down, cell proliferation and metastasis were promoted, while cell apoptosis was suppressed. On the other hand, after the annexinA5 protein was applied to the gastric cancer cells, cell proliferation and metastasis were inhibited, while cell apoptosis and necrosis were promoted. AnnexinA5 played its role
Identifiants
pubmed: 34055631
doi: 10.3389/fonc.2021.665105
pmc: PMC8149956
doi:
Types de publication
Journal Article
Retracted Publication
Langues
eng
Pagination
665105Commentaires et corrections
Type : RetractionIn
Informations de copyright
Copyright © 2021 Wang, Dai, Zhao, Li, Zhang, Ci, Wang and Li.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict.
Références
Oncol Rep. 2014 Dec;32(6):2557-63
pubmed: 25323007
J Cancer Res Ther. 2018 Jul-Sep;14(5):1042-1048
pubmed: 30197345
Cancer Biomark. 2018;23(1):23-32
pubmed: 30010106
Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8054-9
pubmed: 12060752
Oncotarget. 2017 Jul 19;8(43):74263-74275
pubmed: 29088783
J Biol Chem. 2006 Oct 13;281(41):30848-56
pubmed: 16914549
Mol Imaging. 2013 May;12(3):182-90
pubmed: 23490444
Int J Oncol. 2017 May;50(5):1839-1847
pubmed: 28393205
Biomed Pharmacother. 2016 Dec;84:645-654
pubmed: 27697636
Sci Rep. 2013 Dec 20;3:3565
pubmed: 24356445
Oncotarget. 2017 Jun 27;8(26):42602-42612
pubmed: 28402934
Physiol Rev. 2002 Apr;82(2):331-71
pubmed: 11917092
Cancer Immunol Immunother. 2012 Nov;61(11):1917-27
pubmed: 22476407
Tumour Biol. 2014 Dec;35(12):12327-37
pubmed: 25245332
J Clin Gastroenterol. 2009 Oct;43(9):831-7
pubmed: 19461527
Eur Rev Med Pharmacol Sci. 2017 Apr;21(7):1477-1488
pubmed: 28429360
Mol Med Rep. 2012 Dec;6(6):1249-54
pubmed: 22971941
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
Methods Mol Biol. 2016;1419:17-26
pubmed: 27108428
Ann Rheum Dis. 2008 Nov;67(11):1617-25
pubmed: 18218665
J Radiat Res. 2012;53(3):361-7
pubmed: 22739005
BMC Mol Biol. 2006 Oct 06;7:33
pubmed: 17026756